Answers are grounded in this paper and cite their sources.
Tiazofurin is an experimental chemotherapeutic agent currently undergoing clinical evaluation. We report our results with magnetic resonance (MR) in demonstrating reversible cerebral abnormalities concurrent with the use of this drug. The abnormalities on MR were correlated with findings on CT as well as with cerebral angiography. The utility of MR in the evaluation of patients receiving this new agent is illustrated.
No takes yet. Share an insight, caveat, or question.
Rippe et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: